


iStopMM (Iceland screens, treats or prevents multiple myeloma) is a nationwide screening study performed in Iceland


I am deeply saddened by the passing of Dr Brian Durie, a visionary leader, pioneering scientist, and dear friend to me and the @iStopMM team. He worked with us from the very beginning and coauthored all iStopMM papers. His legacy will continue to inspire us.

A new publication from the @iStopMM study, published in @JAMAOnc in 2025, redefines light chain MGUS (LC-MGUS) by introducing new, age-stratified reference intervals for serum free light chains (FLC). 📊🩸 #iStopMM #MultipleMyeloma #mmsm

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance | Nephrology | JAMA Oncology | JAMA Network jamanetwork.com/journals/jam…

🧵1/ Our paper is out! A new study from the iStopMM team in @JAMAOnc shows how revising free light chain (FLC) reference intervals can reduce false positives for light chain MGUS (LC-MGUS). Let’s break it down 👇 jamanetwork.com/journals/jam…

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance @iStopMM @JAMAOnc #mmsm jamanetwork.com/journals/jam… Important data coming to support need for new ranges of normal free light chains based on eGFR👇

Thank you all for participating in our survey! It is still open for those that have not completed it yet. Your input is of great importance! Take part & help spread the word: redcap.link/biopsysurvey
Calling all myeloma experts, nurses, and patients!🩺🧬 The @iStopMM team & @IMFmyeloma need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

The 21st publication from the @iStopMM study, published in Archives of Dermatological Research in 2024, investigates the potential association between monoclonal gammopathies (MGUS, SMM, MM) and alopecia (hair loss). 📊🔬 #iStopMM #dermatology

Calling all myeloma experts, nurses, and patients - @sykristinsson @iStopMM @IMFmyeloma oncodaily.com/blog/sigurdur-… #IMF #MGUS #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

That is the point. Should not represent current practice. We aim to be practice changing ;)

I hear all the cool 😎 ppl are filling out this survey, please fill and retweet! @MyelomaCanada @rajshekharucms @JoshuaRichterMD @HadidiSamer @SurbhiSidanaMD @bdermanmd @RahulBanerjeeMD @sykristinsson
Calling all myeloma experts, nurses, and patients!🩺🧬 The @iStopMM team & @IMFmyeloma need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

There’s no right answer, so tell us yours! Great to see @iStopMM group at it again - patients, nurses, APPs, and physicians can fill out easy survey (written in patient-friendly language) about what % #MMsm risk and pt scenarios might prompt BMBx. redcap.link/biopsysurvey
Calling all myeloma experts, nurses, and patients!🩺🧬 The @iStopMM team & @IMFmyeloma need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

This right here #mmsm peeps! 👇🏽😊
Calling all myeloma experts, nurses, and patients!🩺🧬 The @iStopMM team & @IMFmyeloma need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

Calling all myeloma experts, nurses, and patients!🩺🧬 The @iStopMM team & @IMFmyeloma need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

The 20th publication from the @iStopMM study, a collaborative effort published in @NatureComms in 2024, explores genetic factors underlying multiple myeloma (MM) risk through a genome-wide association study (GWAS). 🧬🔍 #iStopMM #mmsm @IMFmyeloma

The 18th publication from the @iStopMM study, published in @AnnalsofIM in 2024, presents a multivariable model to predict the need for bone marrow (BM) sampling in individuals with monoclonal gammopathy of undetermined significance (MGUS). 🩸📈 #iStopMM #MGUS @IMFmyeloma